Intake & Induction

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).

This publication is intended to aid policymakers, communities, and key stakeholders in developing comprehensive, multi-system strategies that address the opioid crisis.

This virtual public meeting which explored real-world experiences and scientific evidence for buprenorphine initiation strategies, as well as medication dosing and management during continued treatment across different care settings

This fact sheet provides guidance for patients starting buprenorphine outside of hospitals or clinics.

These guidelines provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.

This toolkit provides clinically relevant information to support high-quality delivery of outpatient OUD care via telehealth, while reducing barriers to starting and maintaining both medication and psychosocial treatments.

This web page includes toolkits, guides, and webinars (including on-demand training courses) available from the MOC.

These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.

The VA Opioid Overdose Education & Naloxone Distribution (OEND) Program aims to reduce harm and risk of life-threatening opioid-related overdose and deaths among Veterans. This resource hub includes implementation toolkits, patient & provider guides, overdose education & naloxone distribution vidoes, and additional related VA resources.

This fact sheet provides an overview of the Medication First (or low-barrier maintenance pharmacotherapy) approach to the treatment of opioid use disorders.